论文部分内容阅读
骨髓增生异常综合征 (ＭＤＳ)的治疗较为困难 ,尤其原始细胞增多难治性贫血 (ＲＡＥＢ)及转变中原始细胞增多难治性贫血 (ＲＡＥＢ -Ｔ)预后更为凶险。到目前为止 ,小剂量单药化疗、低剂量联合化疗及常规剂量联合化疗均有报道 ,其结果很不一致。我们于 1995年 1月至 1998年 12
The treatment of myelodysplastic syndrome (MDS) is more difficult, especially in patients with RAEB and RAEB-T. The prognosis is even more dangerous. So far, small-dose single-agent chemotherapy, low-dose combination chemotherapy and conventional-dose combination chemotherapy have been reported, and the results are inconsistent. We were from January 1995 to 1998 12